Waldron Private Wealth LLC Invests $294,000 in Roche Holding AG (OTCMKTS:RHHBY)

Waldron Private Wealth LLC bought a new stake in Roche Holding AG (OTCMKTS:RHHBY) during the 4th quarter, Holdings Channel.com reports. The firm bought 8,120 shares of the company’s stock, valued at approximately $294,000.

Several other institutional investors have also added to or reduced their stakes in the stock. Riverbridge Partners LLC boosted its holdings in Roche by 7.1% in the fourth quarter. Riverbridge Partners LLC now owns 41,407 shares of the company’s stock valued at $1,500,000 after acquiring an additional 2,762 shares during the last quarter. Pacer Advisors Inc. grew its position in shares of Roche by 1,937.5% during the 4th quarter. Pacer Advisors Inc. now owns 1,099,659 shares of the company’s stock worth $39,841,000 after buying an additional 1,045,687 shares during the period. FNY Investment Advisers LLC acquired a new stake in shares of Roche during the 4th quarter worth approximately $362,000. OLD National Bancorp IN grew its position in shares of Roche by 2.0% during the 3rd quarter. OLD National Bancorp IN now owns 251,843 shares of the company’s stock worth $8,619,000 after buying an additional 4,956 shares during the period. Finally, Ramirez Asset Management Inc. acquired a new stake in shares of Roche during the 3rd quarter worth approximately $2,575,000.

Wall Street Analysts Forecast Growth

RHHBY has been the subject of several recent analyst reports. Morgan Stanley downgraded shares of Roche from an “equal weight” rating to an “underweight” rating in a research report on Tuesday, January 16th. Argus reiterated a “hold” rating on shares of Roche in a report on Monday, March 4th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $40.00.

Roche Price Performance

Shares of OTCMKTS:RHHBY opened at $30.58 on Tuesday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.04 and a current ratio of 1.35. The stock’s fifty day simple moving average is $32.25 and its two-hundred day simple moving average is $33.83. Roche Holding AG has a 1-year low of $30.06 and a 1-year high of $40.48.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.